Autoimmune Neurological Disorders and Treatments
Autoimmune Neurological Disorders and Treatments is a research topic within Neurology. Science Explorer counts 13k research works in it since 1950. 13.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on autoimmune encephalitis, particularly the clinical characteristics, diagnostic criteria, and management of conditions such as anti-NMDA receptor encephalitis, paraneoplastic syndromes, and limbic encephalitis. It explores the role of autoantibodies, immunotherapy, and the neurological manifestations of autoimmune diseases. Additionally, it discusses specific conditions like Hashimoto encephalopathy and cognitive impairment associated with these disorders.
- Anti-NMDA Receptor Encephalitis
- Paraneoplastic Syndromes
- Autoantibodies
- Neurological Disorders
- Immunotherapy
- Limbic Encephalitis
- Diagnostic Criteria
- Neuronal Autoantigens
- Hashimoto Encephalopathy
- Cognitive Impairment
- Research works
- 13k fractional, since 1950
- In the world top 10%
- 1.8k per year above
- Top-10% rate
- 13.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +44% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Autoimmune Neurological Disorders and Treatments research?
By volume, the United States and China publish the most (713 and 512 works in 2022–2025).
By volume, 2022–2025
- 1 United States 713 works
- 2 China 512 works
- 3 Japan 211 works
- 4 India 196 works
- 5 Germany 158 works
- 6 United Kingdom 131 works
- 7 Italy 127 works
- 8 France 117 works
- 9 Spain 98 works
- 10 Australia 72 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Autoimmune Neurological Disorders and Treatments research?
By volume in 2022–2025, Mayo Clinic publishes the most Autoimmune Neurological Disorders and Treatments research, followed by Mayo Clinic in Arizona and Capital Medical University.
By volume, 2022–2025
- 1 Mayo ClinicUnited States 18 works
- 2 Mayo Clinic in ArizonaUnited States 17 works
- 3 Capital Medical UniversityChina 17 works
- 4 National Institute of Mental Health and NeurosciencesIndia 15 works
- 5 First Affiliated Hospital of Zhengzhou UniversityChina 14 works
- 6 All India Institute of Medical SciencesIndia 13 works
- 7 Sichuan UniversityChina 13 works
- 8 Mayo Clinic in FloridaUnited States 12 works
- 9 Gifu UniversityJapan 12 works
- 10 InsermFrance 12 works
Who are the leading researchers in Autoimmune Neurological Disorders and Treatments?
The most-cited researchers publishing on Autoimmune Neurological Disorders and Treatments include Kāri Stefánsson.
- 1 Kāri Stefánsson Iceland 4.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Autoimmune Neurological Disorders and Treatments research done?
The largest centres of Autoimmune Neurological Disorders and Treatments research in 2022–2025 are Beijing (China), Tokyo (Japan), Paris (France) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Cleveland.
Largest cities, 2022–2025
Where it is the local speciality
- ClevelandUS · 26.8 works6.1×
Location quotient: how much more of its research is in Autoimmune Neurological Disorders and Treatments than the world average.
Where is the best place to study Autoimmune Neurological Disorders and Treatments?
Among universities, judged by research, Capital Medical University, All India Institute of Medical Sciences and Gifu University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Capital Medical UniversityChina | 61.6 | 9.6% | 9.3× | 16 | +155.0% |
| 2 | All India Institute of Medical SciencesIndia | 45.8 | 4.3% | 7.1× | 13 | +182.7% |
| 3 | Gifu UniversityJapan | 40.2 | 2.1% | 34.8× | 12 | +21.3% |
| 4 | Johns Hopkins UniversityUnited States | 39.0 | 18.9% | 3.5× | 12 | +50.2% |
| 5 | University College LondonUnited Kingdom | 37.7 | 25.3% | 2.2× | 9 | +24.2% |
| 6 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 34.2 | 14.7% | 2.8× | 8 | +420.4% |
| 7 | Sichuan UniversityChina | 33.5 | 15.0% | 2.4× | 12 | — |
| 8 | University of OxfordUnited Kingdom | 33.0 | 26.8% | 2.1× | 8 | +1.4% |
| 9 | Central South UniversityChina | 28.9 | 20.1% | 1.8× | 9 | — |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Autoimmune Neurological Disorders and Treatments research growing?
Output in 2018–2022 was 44% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Autoimmune Neurological Disorders and Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.